|
| |
aerolytic phase 2a Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - AEROVANCE, INC
24 Sep 2008 ... an IL-4 and IL-13 receptor antagonist currently in Phase 2a studies for asthma; AEROLYTIC™, a serine protease inhibitor in Phase 2a for ...
http://www.bioportfolio.com/biocorporate/17964-AEROVANCE,_IN...
|
Aerovance, Inc. Appoints William J. Newell< - News, Search Jobs ...
... for severe asthma and eczema currently in Phase 2 studies, and Aerolytic(TM) , a recombinant protein for CF and COPD currently in Phase 1/2a studies. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=9122...
|
Aerovance, Inc. Adds Accomplished Product Commercialization ...
... and Aerolytic(TM), a recombinant protein for the treatment of cystic fibrosis ... are progressing rapidly through Phase 2a clinical trials," said
Perry. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=40400...
|
|
